Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04797039 · ClinicalTrials.gov registry record
MRI-Guided Cryoablation for Focal Native Prostate Cancer
A clinical trial of Primary Malignant Neoplasm of Prostate (Diagnosis), sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04797039 is a study of Primary Malignant Neoplasm of Prostate (Diagnosis) that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04797039, a study of Primary Malignant Neoplasm of Prostate (Diagnosis), is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed. Participants have been asked to take part in this research because the participants have been diagnosed with prostate cancer and scheduled to have an ablation procedure.
Conditions Studied
Interventions
- PROCEDURE MR guided cryoablation
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04797039
The ClinicalTrials.gov registry entry for NCT04797039 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Malignant Neoplasm of Prostate (Diagnosis) appearing as the primary indexed condition, and to 1 intervention - of which MR guided cryoablation is the first listed.
NCT04797039 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04797039 about?
NCT04797039 is a clinical study titled "MRI-Guided Cryoablation for Focal Native Prostate Cancer". The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed. Participants have been asked ...
What is the current status of trial NCT04797039?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2020-12-01. Estimated completion is 2030-12.
What conditions does trial NCT04797039 study?
This clinical trial studies the following conditions: Primary Malignant Neoplasm of Prostate (Diagnosis).
What interventions are being tested in trial NCT04797039?
The interventions under investigation include: MR guided cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT04797039?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04797039 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.